Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. The company is headquartered in New Delhi, Delhi and currently employs 237 full-time employees. The company went IPO on 2015-05-22. The firm is the producer of Dimethoate Technical and the Malathion Technical in India. The company also manufactures organophosphorus-based insecticides and chemicals. Its business units include API, Formulation, Research and Development, Agrochemical, Specialty Chemicals and Intellectual Property. The company offers solutions from product selection to development till commercialization for a range of oncology and non-oncology products. Its oncology products include Azacitidine, Busulfan, Bortezomib, and various others. Its non-oncology products include Fingolimod, Pirfenidone, Ambroxol HCL, and others. Its Dimethoate Technical is used in preparation of formulations used in the control of a range of insect and mites. Its Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide used for a variety of food/feed crops.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.